BAX 826 Dose-Escalation Safety Study (Q66407999)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BAX 826 Dose-Escalation Safety Study |
clinical trial |
Statements
A Phase 1, Prospective, Open Label, Two Period, Fixed Sequence, Dose-Escalation Study of the PK and Safety of BAX 826 (PSA-rFVIII) in Previously Treated Patients With Severe (FVIII <1%) Hemophilia A (English)
0 references
3 March 2016
0 references
17 January 2017
0 references
40
0 references
18 year
0 references
65 year
0 references